Dan Li is a Scientific Director in Quantitative Pharmacology and Pharmacometrics (QP2) at Merck, where they have held various roles including Associate Principal Scientist from 2021 to 2023. They completed internships at Johnson & Johnson in 2010 and Genentech in 2016, where they developed a time-to-event model for immunogenicity. Dan's academic background includes a Ph.D. in Pharmaceutical Sciences and a dual Master's degree in Statistics from the University of Michigan, along with a Master's and a Bachelor’s degree in Pharmacy and Pharmaceutical Sciences, and Economics from Peking University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices